Earnings History Data for Caladrius Biosciences, Inc. (CLBS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Caladrius Biosciences, Inc.

Caladrius Biosciences, Inc. is an immunotherapy company which specializes in cell process optimization, development and manufacturing. Its product candidate consists of NBS20, a targeted cancer immunotherapy product for the treatment of metastatic melanoma; NBS10, an ischemic repair product to preserve heart muscle function following an acute myocardial infarction and NBS03D, an immune modulation product for the treatment of diabetes which are in different clinical trials. Caladrius Biosciences, Inc., formerly known as NeoStem, Inc., is headquartered in New York.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
04-08-2022 AH 4:05 PM ET
(Aug 4)		 CLBS Caladrius Biosciences, Inc. 32.68 -0.11 -0.10 -0.10 Caladrius Biosciences GAAP EPS of -$0.11 beats by $0.01
[8/4/2022 5:10 PM]		 0.5161 0.0 
(-0.71%)		 0.51 -0.01 
(-1.89%)		 0.40 - 1.34 314,154 160,000 163
05-05-2022 AH 4:05 PM ET
(May 5)		 CLBS Caladrius Biosciences, Inc. 31.59 -0.07 -0.10 -0.19 Caladrius Biosciences GAAP EPS of -$0.07
[5/5/2022 4:29 PM]		 0.46 -0.06 
(-11.20%)		 0.54 0.02 
(4.63%)		 0.45 - 1.68 543,284 1,240,000 21,421
22-03-2022 AH 4:05 PM ET
(Mar 22)		 CLBS Caladrius Biosciences, Inc. 44.06 -0.11 -0.14 -0.28 Caladrius Biosciences GAAP EPS of -$0.11
[3/22/2022 4:06 PM]		 0.7298 -0.01 
(-1.38%)		 0.7410 0.0 
(0.14%)		 0.63 - 2.08 260,687 350,000 13,466
04-11-2021 AH 4:05 PM ET
(Nov 4)		 CLBS Caladrius Biosciences, Inc. 69.64 -0.12 -0.13 -0.29 Caladrius Biosciences EPS beats by $0.01
[11/4/2021 4:29 PM]		 1.13 -0.04 
(-3.42%)		 1.15 -0.02 
(-1.71%)		 1.09 - 4.89 561,369 390,000 7,510
05-08-2021 AH 4:05 PM ET
(Aug 5)		 CLBS Caladrius Biosciences, Inc. 79.13 -0.10 -0.15 -0.33 Caladrius Biosciences EPS beats by $0.04
[8/5/2021 4:12 PM]		 1.28 -0.01 
(-0.78%)		 1.29 0.0 
(0.00%)		 1.25 - 4.89 282,717 340,000 28,531
06-05-2021 AH 4:05 PM ET
(May 6)		 CLBS Caladrius Biosciences, Inc. 94.01 -0.19 -0.09 -0.38 Caladrius Biosciences EPS misses by $0.10
[5/6/2021 4:10 PM]		 1.51 0.01 
(0.33%)		 1.51 0.0 
(0.00%)		 1.25 - 4.89 794,205 580,000 6,286
25-02-2021 AH 4:05 PM ET
(Feb 25)		 CLBS Caladrius Biosciences, Inc. 61.65 -0.28 -0.27 -0.47 Caladrius Biosciences EPS misses by $0.02
[2/25/2021 4:10 PM]		 1.79 -0.12 
(-6.21%)		 1.82 -0.09 
(-4.71%)		 1.05 - 4.89 3,899,979 13,475,451 302,823
05-11-2020 AH 4:05 PM ET
(Nov 5)		 CLBS Caladrius Biosciences, Inc. 30.72 -0.29 -0.30 -0.47 Caladrius Biosciences EPS misses by $0.06
[11/5/2020 4:17 PM]		 1.50 -0.11 
(-6.83%)		 1.58 -0.03 
(-1.86%)		 1.05 - 3.64 156,460 116,998 1,459
13-08-2020 AH 4:05 PM ET
(Aug 13)		 CLBS Caladrius Biosciences, Inc. 34.68 -0.33 -0.36 -0.49 2.36 0.20 
(9.53%)		 2.33 0.18 
(8.37%)		 1.05 - 3.64 528,561 490,377 26,957